The first 48 hours: Comparing 12-hour and 24-hour betamethasone dosing when preterm deliveries occur rapidly

Area of Science:

• Obstetrics and Gynecology
• Neonatal Medicine
• Pharmacology

Background:

• Antenatal corticosteroids like betamethasone are crucial for accelerating fetal lung maturity in preterm pregnancies.
• Standard dosing involves administering betamethasone every 24 hours.
• The optimal dosing interval for betamethasone when delivery is anticipated within 48 hours requires further investigation.

Purpose of the Study:

• To compare neonatal outcomes between 12-hour and 24-hour betamethasone dosing regimens.
• To evaluate the efficacy of accelerated betamethasone dosing in preventing adverse neonatal outcomes in cases of imminent preterm delivery.

Main Methods:

• Retrospective chart review of preterm deliveries between 1996 and 2000.
• Analysis of neonatal outcomes for deliveries occurring within 48 hours of antenatal steroid initiation.
• Comparison of outcomes between women receiving betamethasone every 12 hours versus every 24 hours.

Main Results:

• No statistically significant differences were observed in respiratory distress syndrome, surfactant use, chronic lung disease, intraventricular hemorrhage, or neonatal death rates.
• A statistically significant difference was noted in venous cord blood pH (7.27 vs. 7.32, p = 0.01).
• Subgroup analysis by delivery time (0-24 vs. 24-48 hours) showed no significant differences, though limited by small sample sizes.

Conclusions:

• Betamethasone dosing every 12 hours may yield comparable neonatal outcomes to the standard 24-hour regimen when delivery occurs within 48 hours.
• The findings suggest that a 12-hour dosing interval is a viable alternative for antenatal steroid therapy in specific clinical scenarios.
• Further research with larger sample sizes is warranted to confirm these findings and explore potential nuances in neonatal outcomes.